BR100 Decreased By (-0.23%)
BR30 Decreased By (-0.01%)
KSE100 Decreased By (-0.19%)
KSE30 Decreased By (-0.24%)
AGHA 7.74 Increased By ▲ 0.05 (0.65%)
BECO 5.29 Decreased By ▼ -0.02 (-0.38%)
BML 60.01 Decreased By ▼ -1.22 (-1.99%)
BOP 36.46 Increased By ▲ 0.46 (1.28%)
CNERGY 11.94 Increased By ▲ 0.69 (6.13%)
CSIL 6.17 No Change ▼ 0.00 (0%)
FCCL 57.36 Increased By ▲ 0.48 (0.84%)
FFL 16.58 Increased By ▲ 0.07 (0.42%)
FNEL 1.20 No Change ▼ 0.00 (0%)
KEL 7.32 Decreased By ▼ -0.10 (-1.35%)
KOSM 6.05 No Change ▼ 0.00 (0%)
LOTCHEM 27.14 Decreased By ▼ -0.06 (-0.22%)
MLCF 102.07 Decreased By ▼ -1.02 (-0.99%)
NBP 206.35 Decreased By ▼ -1.28 (-0.62%)
NCPL 62.62 Increased By ▲ 0.70 (1.13%)
NPL 71.98 Decreased By ▼ -0.20 (-0.28%)
OGDC 319.19 Increased By ▲ 0.70 (0.22%)
PACE 11.38 Increased By ▲ 0.32 (2.89%)
PAEL 43.88 Decreased By ▼ -0.50 (-1.13%)
PIBTL 16.84 Decreased By ▼ -0.06 (-0.36%)
PPL 221.55 Decreased By ▼ -0.93 (-0.42%)
PRL 63.75 Decreased By ▼ -0.06 (-0.09%)
PTC 72.41 Decreased By ▼ -0.75 (-1.03%)
SSGC 27.28 Increased By ▲ 0.03 (0.11%)
TBL 9.86 Decreased By ▼ -0.02 (-0.2%)
TELE 8.62 Decreased By ▼ -0.19 (-2.16%)
TPL 20.68 Increased By ▲ 0.34 (1.67%)
TPLP 14.98 Increased By ▲ 0.01 (0.07%)
TREET 24.10 No Change ▼ 0.00 (0%)
TRG 63.29 Increased By ▲ 0.92 (1.48%)
By

NEW YORK: Morgan Stanley’s revenue beat fourth-quarter expectations on Tuesday, helped by a rebound in dealmaking activity, sending the shares of the investment bank up 1% in premarket trading.

Several high-profile initial public offerings and merger announcements toward the end of last year sparked optimism about a nascent recovery in dealmaking in 2024.

“We begin 2024 with a clear and consistent business strategy and a unified leadership team,” CEO Ted Pick said in a statement. “We are focused on achieving our long-term financial goals and continuing to deliver for shareholders.” Morgan Stanley is among the banking giants that are paying special fees to replenish a government deposit insurance fund that was drained by almost $16 billion after the collapse of two regional lenders last year.

It took a combined $535 million in charges, which included $286 million in special assessment fee to the regulator and $249 million in legal charges.

Morgan Stanley’s investment banking revenue rose 5% in the fourth quarter from a year ago, outperforming the broader industry.

Net revenue came in at $12.9 billion compared with analysts’ expectations of $12.75 billion, according to LSEG data.

Its net income fell to $1.5 billion, or 85 cents per diluted share, in the three months ended Dec. 31, compared with $2.2 billion, or $1.26 per diluted share, a year ago.

The gain in investment banking driven by M&A advisory was “encouraging,” wrote Chris Kotowski, an analyst at brokerage Oppenheimer.

Comments

Comments are closed for this article.